Quality of life and disparities among long-term cervical cancer survivors

2014 ◽  
Vol 8 (3) ◽  
pp. 419-426 ◽  
Author(s):  
Howard P. Greenwald ◽  
Ruth McCorkle ◽  
Kathy Baumgartner ◽  
Carolyn Gotay ◽  
Anne Victoria Neale
2005 ◽  
Vol 97 (2) ◽  
pp. 310-317 ◽  
Author(s):  
Lari Wenzel ◽  
Israel DeAlba ◽  
Rana Habbal ◽  
Brenda Coffey Kluhsman ◽  
Diane Fairclough ◽  
...  

2005 ◽  
Vol 5 (3) ◽  
pp. 157-158
Author(s):  
Brigitte Miller

2013 ◽  
Vol 129 (1) ◽  
pp. 222-228 ◽  
Author(s):  
Gwenael Le Borgne ◽  
Mariette Mercier ◽  
Anne-Sophie Woronoff ◽  
Anne-Valérie Guizard ◽  
Edwige Abeilard ◽  
...  

Cancers ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 317
Author(s):  
Mihai Stanca ◽  
Dan Mihai Căpîlna ◽  
Cristian Trâmbițaș ◽  
Mihai Emil Căpîlna

(1) Background: Cervical cancer patients have been found to have worse quality of life (QoL) scores due to cancer treatment, not only when compared to the general population, but also when compared to other gynecological cancer survivors. In Eastern European developing countries, the health care system often cannot afford the uppermost standardized treatment for these patients. In the absence of a comparable study in our country, the authors’ aim for this retrospective cross-sectional observational study was to evaluate the overall survival (OS) and the QoL o cervical cancer survivors; (2) Methods: 430 patients were analyzed. The first objective is to evaluate the OS rates of patients with cervical cancer stages IA2 to IIB undergoing radical hysterectomy (RH) +/− neoadjuvant or adjuvant radiotherapy +/− chemoradiotherapy treatment combinations. The second objective is to assess their QoL, using two standardized questionnaires issued by the European Organisation for Research and Treatment of Cancer (EORTC), namely QLQ-C30 and QLQ-CX24. (3) Results: The mean age of the participants was 51 years (22–76) and the average follow-up time was 65 months (2–128). At the time of the analysis, 308 out of 430 patients were alive, with a mean five-year OS of 72.4%. The multivariate Cox regression analysis identified stage IIB, parametrial invasion, and the lymph node metastases as independent prognostic risk factors negatively impacting the OS. Of the 308 patients still alive at the time of the analysis, 208 (68%) answered the QoL questionnaires. The QLQ-C30 shows a good long-term Global QoL of 64.6 (median), good functioning scores, and a decent symptom scale value. However, the EORTC QLQ-CX24 showed high values of cervical cancer-specific symptoms, namely: lymphedema, peripheral neuropathy, severe menopausal symptoms, and distorted body-image perception. The results also indicate a significant decline in the quality of sexual life with a low sexual enjoyment and decreased level of sexual activities. (4) Conclusion: Despite a good OS, in this setting of patients, cervical cancer survivors have a modest QoL and sexual function. Our study may provide a comparison for future randomized, controlled trials in Eastern European countries needing to confirm these results.


2005 ◽  
Vol 5 (3) ◽  
pp. 157-158
Author(s):  
Brigitte E. Miller

2015 ◽  
Vol 51 ◽  
pp. S540
Author(s):  
J. Khalil ◽  
H. Elkacemi ◽  
N. Sahli ◽  
F. El Omrani ◽  
T. Kebdani ◽  
...  

2008 ◽  
Vol 173 (10) ◽  
pp. 1035-1041 ◽  
Author(s):  
Carolyn C. Gotay ◽  
John H. Farley ◽  
Crissy Terawaki Kawamoto ◽  
Adela Mearig

2004 ◽  
Vol 13 (1) ◽  
pp. 49-56 ◽  
Author(s):  
Sigrid Pemberger ◽  
Reinhold Jagsch ◽  
Eva Frey ◽  
Rosemarie Felder-Puig ◽  
Helmut Gadner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document